Iranian scientists develop device for genetic, cancer diagnostics

A team of innovators from an Iranian knowledge-based company has successfully developed a cutting-edge device capable of diagnosing genetic disorders and cancers both before and after birth.

Maedeh Ashjaei, CEO of the company, highlighted their achievements since the company’s establishment in 2006. “We have developed around 50 products, focusing on laboratory and genetic devices. One of our flagship innovations is the thermocycler, which plays a pivotal role in early disease detection,” she stated.

This advanced device, in use since 2014, significantly reduces reliance on foreign equipment, cutting costs and preventing capital outflow. The thermocycler is used in DNA amplification for disease diagnostics in genetic and clinical laboratories. Its capability to detect conditions early, particularly cancers, has made it a crucial tool in medical diagnostics.

Ashjaei emphasized the device’s affordability and accessibility, priced at 115 million tomans with 25% financial support from the Vice Presidency for Science and Technology. In contrast, foreign counterparts cost over 300 million tomans.

With over 100 units already in use nationwide, the thermocycler offers a 10-year after-sales service, ensuring reliability and customer satisfaction. This innovation not only curbs foreign dependency but also boosts the local laboratory infrastructure, creating significant economic and technological value.